- Home
- FGEN vs OKYO Comparison
FGEN vs OKYO Comparison
Compare FGEN & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGEN
- OKYO
- Stock Information
- Founded
- FGEN 1993
- OKYO 2007
- Country
- FGEN United States
- OKYO United Kingdom
- Employees
- FGEN N/A
- OKYO N/A
- Industry
- FGEN Biotechnology: Pharmaceutical Preparations
- OKYO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FGEN Health Care
- OKYO Health Care
- Exchange
- FGEN Nasdaq
- OKYO Nasdaq
- Market Cap
- FGEN 33.5M
- OKYO 37.0M
- IPO Year
- FGEN 2014
- OKYO 2022
- Fundamental
- Price
- FGEN $5.61
- OKYO $2.76
- Analyst Decision
- FGEN Strong Buy
- OKYO Strong Buy
- Analyst Count
- FGEN 1
- OKYO 1
- Target Price
- FGEN $250.00
- OKYO $7.00
- AVG Volume (30 Days)
- FGEN 60.2K
- OKYO 217.1K
- Earning Date
- FGEN 08-05-2025
- OKYO 08-12-2025
- Dividend Yield
- FGEN N/A
- OKYO N/A
- EPS Growth
- FGEN N/A
- OKYO N/A
- EPS
- FGEN N/A
- OKYO N/A
- Revenue
- FGEN $6,996,000.00
- OKYO N/A
- Revenue This Year
- FGEN N/A
- OKYO N/A
- Revenue Next Year
- FGEN N/A
- OKYO N/A
- P/E Ratio
- FGEN N/A
- OKYO N/A
- Revenue Growth
- FGEN N/A
- OKYO N/A
- 52 Week Low
- FGEN $4.50
- OKYO $0.81
- 52 Week High
- FGEN $38.25
- OKYO $3.11
- Technical
- Relative Strength Index (RSI)
- FGEN 39.07
- OKYO 63.68
- Support Level
- FGEN $4.85
- OKYO $2.05
- Resistance Level
- FGEN $5.77
- OKYO $2.92
- Average True Range (ATR)
- FGEN 0.57
- OKYO 0.29
- MACD
- FGEN -0.02
- OKYO 0.02
- Stochastic Oscillator
- FGEN 31.67
- OKYO 68.87
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.